Expensive blood safety initiatives may offer less benefit than we think
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Expensive blood safety initiatives may offer less benefit than we think. / Kamper-Jørgensen, Mads; Hjalgrim, Henrik; Edgren, Gustaf; Titlestad, Kjell; Ullum, Henrik; Shanwell, Agneta; Reilly, Marie; Melbye, Mads; Nyrén, Olof; Rostgaard, Klaus.
In: Transfusion, Vol. 50, No. 1, 01.2010, p. 240-2.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Expensive blood safety initiatives may offer less benefit than we think
AU - Kamper-Jørgensen, Mads
AU - Hjalgrim, Henrik
AU - Edgren, Gustaf
AU - Titlestad, Kjell
AU - Ullum, Henrik
AU - Shanwell, Agneta
AU - Reilly, Marie
AU - Melbye, Mads
AU - Nyrén, Olof
AU - Rostgaard, Klaus
PY - 2010/1
Y1 - 2010/1
N2 - Various blood safety initiatives have ensured a historically low risk of infection transmission through blood transfusion. Although further prevention of infection transmission is possible through, for example, nucleic acid testing and future introduction of pathogen inactivation, such initiatives are very costly in relation to the benefit they offer. Although estimation of the cost-effectiveness requires detailed information about the survival of transfusion recipients, previous cost-effectiveness analyses have relied on incorrect survival assumptions.
AB - Various blood safety initiatives have ensured a historically low risk of infection transmission through blood transfusion. Although further prevention of infection transmission is possible through, for example, nucleic acid testing and future introduction of pathogen inactivation, such initiatives are very costly in relation to the benefit they offer. Although estimation of the cost-effectiveness requires detailed information about the survival of transfusion recipients, previous cost-effectiveness analyses have relied on incorrect survival assumptions.
KW - Blood Banks
KW - Blood Transfusion
KW - Cost-Benefit Analysis
KW - Follow-Up Studies
KW - Humans
KW - Infection
KW - Infection Control
KW - Quality of Health Care
KW - Quality-Adjusted Life Years
KW - Risk Factors
KW - Scandinavia
KW - Survival Analysis
U2 - 10.1111/j.1537-2995.2009.02374.x
DO - 10.1111/j.1537-2995.2009.02374.x
M3 - Journal article
C2 - 19761551
VL - 50
SP - 240
EP - 242
JO - Transfusion
JF - Transfusion
SN - 0041-1132
IS - 1
ER -
ID: 32340624